1/2 Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease (Tele-COPD)

1/2 视频 远程医疗肺康复可减少慢性阻塞性肺疾病 (Tele-COPD) 的再入院率

基本信息

  • 批准号:
    10505270
  • 负责人:
  • 金额:
    $ 180.22万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2027-07-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract Acute exacerbations of chronic obstructive pulmonary disease (COPD) result in significant morbidity and healthcare costs, especially severe exacerbations that require hospitalization. Traditional bronchodilators and anti- inflammatory medications, as well as programs to monitor and treat symptoms, have a modest effect on reducing hospital admissions. Readmission rates remain unacceptably high, so alternative approaches are needed. In this regard, pulmonary rehabilitation (PR) is remarkably effective, and is associated with an 80% reduction in admission rates. Successful completion of PR is also associated with substantial improvements in quality of life, dyspnea, as well as exercise tolerance. Despite these benefits, recent studies have highlighted very poor referral rates for PR overall and as low as 1.9% post-hospitalization, and non-completion rates as high as 60%. The poor adaptation of PR in the community is due to a combination of barriers in availability and accessibility, as well as attrition. The number of PR centers in the United States is inadequate, and these centers are mostly distributed in urban areas. In addition, multiple socioeconomic and medical barriers hinder access to PR, and contribute to high drop-out rates. New strategies are needed to reduce hospital readmission in COPD, and to increase the delivery of PR to underserved urban as well as rural areas in the community. Given the scarcities in existing resources, conventional models of care delivery are being challenged, and attempts are being made to find alternative, cost-effective ways of delivering healthcare to a larger number of eligible patients. To overcome the socioeconomic and physical barriers to PR, we hypothesize that a video telehealth intervention that will deliver PR to the patient's home, regardless of geographic location, will reduce hospital readmissions in COPD, and reduce respiratory morbidity. To test our hypothesis we propose a prospective randomized controlled phase 3 multicenter clinical trial comparing a real-time video telehealth PR intervention plus standard of care versus standard of care alone, with the following Specific Aims: (1) To determine if a video telehealth PR intervention reduces 30-day all-cause readmissions in patients hospitalized for acute exacerbation of COPD, (2) To evaluate the effects of the video telehealth PR intervention on dyspnea and respiratory quality of life in COPD post hospital discharge, and (3) To evaluate the cost-effectiveness of the telehealth intervention. Accomplishment of the aims of this study will result in a significant reduction in COPD readmission rates, and a paradigm shift in the way PR is delivered to patients with COPD, especially those that reside in remote and rural areas with limited access to pulmonary rehabilitation.
项目摘要/摘要 慢性阻塞性肺疾病(COPD)的急性加重导致明显的发病率和 医疗保健费用,尤其是严重的恶化,需要住院。传统的支气管扩张剂和抗 炎症药物以及监测和治疗症状的程序,对减少 住院入院。再入院率仍然不可接受,因此需要替代方法。在这个 考虑到肺康复(PR)非常有效,并且降低了80% 费率。成功完成PR还与生活质量的大幅改善有关,呼吸困难 以及运动耐受性。尽管有这些好处,但最近的研究突显了PR的转介率很差 总体而言,总院后1.9%,不完整率高达60%。不良改编 社区中的PR是由于可用性和可及性障碍以及损耗的结合。这 美国的公关中心数量不足,这些中心主要分布在城市地区。 此外,多个社会经济和医疗障碍阻碍了PR的通道,并导致了高辍学率。 需要采取新的策略来减少COPD中的医院再入院,并增加公关的交付 社区中服务不足的城市和农村地区。鉴于现有资源的稀缺,常规 护理交付模式正在受到挑战,并正在尝试寻找替代性,成本效益的方式 向更多合格患者提供医疗保健。克服社会经济和身体 PR的障碍,我们假设视频远程医疗干预将为患者的家提供PR 无论地理位置如何,都会减少COPD中的医院再入院,并降低呼吸道发病率。到 检验我们的假设,我们提出了一项前瞻性随机控制阶段3多中心临床试验,比较 实时视频远程医疗PR干预加上护理标准与护理标准,以下 具体目的:(1)确定视频远程医疗PR干预是否减少了30天的全因再入院 患者因急性加重COPD住院,(2)评估视频远程医疗PR的影响 COPD医院出院后的呼吸困难和呼吸质量的干预,(3)评估 远程医疗干预的成本效益。实现这项研究的目标将导致重大 降低COPD再入院率,以及将PR传递给COPD患者的方式的范式转变, 尤其是那些居住在偏远和农村地区的肺部康复。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Surya P. Bhatt其他文献

Rapid Recurrence of Interstitial Fibrosis Following Lung Transplantation
  • DOI:
    10.1378/chest.10155
  • 发表时间:
    2010-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Surya P. Bhatt;Kalpaj R. Parekh;Lois J. Geist;Jamie Weydert;Julia A. Klesney-Tait
  • 通讯作者:
    Julia A. Klesney-Tait
β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol
β-受体阻滞剂预防慢性阻塞性肺疾病急性加重 (βLOCK COPD):一项随机对照研究方案
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Surya P. Bhatt;J. Connett;H. Voelker;Sarah M Lindberg;Elizabeth Westfall;Wells Jn;Stephen C. Lazarus;G. Criner;M. Dransfield
  • 通讯作者:
    M. Dransfield
Tension Pneumothorax: A Complication of Superior Vena Cava Filter Insertion
  • DOI:
    10.1016/j.athoracsur.2007.12.055
  • 发表时间:
    2008-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Surya P. Bhatt;Sudip Nanda;Mohamed A. Turki
  • 通讯作者:
    Mohamed A. Turki
Effect of tripod position on objective parameters of respiratory function in stable chronic obstructive pulmonary disease.
三脚架位置对稳定型慢性阻塞性肺疾病呼吸功能客观参数的影响。
Combined FEV1 and FVC Bronchodilator Response, Exacerbations, and Mortality in COPD.
COPD 中 FEV1 和 FVC 支气管扩张剂反应、病情加重和死亡率的组合。
  • DOI:
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    8.3
  • 作者:
    Spyridon Fortis;A. Comellas;B. Make;C. Hersh;S. Bodduluri;D. Georgopoulos;Victor Kim;Gerard J. Criner;M. Dransfield;Surya P. Bhatt
  • 通讯作者:
    Surya P. Bhatt

Surya P. Bhatt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Surya P. Bhatt', 18)}}的其他基金

1/2 Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease (Tele-COPD)
1/2 视频 远程医疗肺康复可减少慢性阻塞性肺疾病 (Tele-COPD) 的再入院率
  • 批准号:
    10300304
  • 财政年份:
    2021
  • 资助金额:
    $ 180.22万
  • 项目类别:
Structural Determinants of Disease Progression in COPD
COPD 疾病进展的结构决定因素
  • 批准号:
    10593047
  • 财政年份:
    2020
  • 资助金额:
    $ 180.22万
  • 项目类别:
Structural Determinants of Disease Progression in COPD
COPD 疾病进展的结构决定因素
  • 批准号:
    10374005
  • 财政年份:
    2020
  • 资助金额:
    $ 180.22万
  • 项目类别:
Deep Learning and Fluid Dynamics Based Phenotyping of Expiratory Central Airway Collapse
基于深度学习和流体动力学的呼气中央气道塌陷表型分析
  • 批准号:
    10013198
  • 财政年份:
    2019
  • 资助金额:
    $ 180.22万
  • 项目类别:
Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of Chronic Obstructive Pulmonary Disease
慢性阻塞性肺疾病的舒张功能障碍和少发性炎症急性加重
  • 批准号:
    9981812
  • 财政年份:
    2016
  • 资助金额:
    $ 180.22万
  • 项目类别:
Assignment of "Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of Chronic Obstructive Pulmonary Disease"
“慢性阻塞性肺疾病的舒张功能障碍和少发性炎症急性加重”作业
  • 批准号:
    9163363
  • 财政年份:
    2016
  • 资助金额:
    $ 180.22万
  • 项目类别:
Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of Chronic Obstructive Pulmonary Disease
慢性阻塞性肺疾病的舒张功能障碍和少发性炎症急性加重
  • 批准号:
    9753343
  • 财政年份:
    2016
  • 资助金额:
    $ 180.22万
  • 项目类别:

相似国自然基金

阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
  • 批准号:
    82302281
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
  • 批准号:
    82300697
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
  • 批准号:
    22304039
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
  • 批准号:
    82300173
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
  • 批准号:
    82360957
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Racial Differences in Hospital-Associated Disability and Acute and Post-Acute Care Physical Therapy Utilization
医院相关残疾以及急性和急性后护理物理治疗利用的种族差异
  • 批准号:
    10785500
  • 财政年份:
    2023
  • 资助金额:
    $ 180.22万
  • 项目类别:
Developing and Determining Feasibility of a Novel Upper Extremity Robotic Exoskeleton to Track and Target Unwanted Joint Synergies during Repetitive Task Training in Stroke Survivors
开发并确定新型上肢机器人外骨骼的可行性,以跟踪和瞄准中风幸存者重复任务训练期间不需要的关节协同作用
  • 批准号:
    10805748
  • 财政年份:
    2023
  • 资助金额:
    $ 180.22万
  • 项目类别:
Synergizing home health rehabilitation therapy to optimize patients’ activities of daily living
协同家庭健康康复治疗,优化患者的日常生活活动
  • 批准号:
    10429480
  • 财政年份:
    2022
  • 资助金额:
    $ 180.22万
  • 项目类别:
Synergizing home health rehabilitation therapy to optimize patients’ activities of daily living
协同家庭健康康复治疗,优化患者的日常生活活动
  • 批准号:
    10621820
  • 财政年份:
    2022
  • 资助金额:
    $ 180.22万
  • 项目类别:
Development and Feasibility of a Behavioral Activation Intervention to Support Independence in Older Veterans at Risk for Functional Decline
行为激活干预措施的开发和可行性,以支持面临功能衰退风险的老年退伍军人的独立性
  • 批准号:
    10538999
  • 财政年份:
    2022
  • 资助金额:
    $ 180.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了